Navigation Links
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Date:12/20/2007

REDWOOD CITY, Calif., Dec. 20 /PRNewswire/ -- Pearl Therapeutics, Inc., a biopharmaceutical company developing treatments for major respiratory diseases, today announced the appointment of Colin Reisner, MD, FCCP, FAAAAI to the position of Chief Medical Officer and Executive Vice President of Clinical Development and Medical Affairs, and Michael Golden to the position of Vice President, Regulatory Affairs and Quality.

"We are delighted to welcome Colin and Michael as we continue to build our team with experts in the development of respiratory products," said Adrian Smith, President, Pearl Therapeutics, Inc. "Both Colin and Michael have proven records of success in the pharmaceutical industry and are innovative leaders who have designed and managed the clinical and CMC development programs of many marketed products, from pre-clinical through NDA filing and commercialization."

Dr. Reisner joins Pearl from Novartis Pharmaceuticals where he was Executive Director and former Disease Area Section Head for Global Respiratory Development, a position focused on both clinical development leadership and shaping Novartis' global strategy for respiratory products. He led the clinical development activities of several programs in asthma, COPD, and cystic fibrosis, assessing single and combination therapies across a wide range of delivery systems and dosage forms. Earlier at Novartis, Dr. Reisner served as the Global Brand Medical Director for Xolair(R), the first biologic agent approved for asthma. In this capacity, he oversaw all clinical activities ranging from design and implementation of the pediatric development program to the European approval for the treatment of severe persistent allergic asthma.

Prior to Novartis, Dr. Reisner served as Senior Director in the Respiratory Division at GlaxoSmithKline, and as the International Project Leader for beta agonists. Dr. Reisner played a diverse and integral role in the development of several key product
'/>"/>

SOURCE Pearl Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pearl Therapeutics Raises $15.5 Million in Private Financing
2. String of fullerene pearls
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
5. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
6. Nile Therapeutics, Inc. Adds to Executive Management Team
7. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
10. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
11. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... ... have clarified the function of three proteins that play a central role in the circadian clock ... the engineering of plant clock systems, with powerful applications to agriculture. , ... (PRWeb UK) March 17, 2010 -- Researchers at the RIKEN ...
(Date:3/17/2010)... a single atom thicknow appears to be a promising ... at the National Institute of Standards and Technology (NIST) ... of graphene layers could potentially store hydrogen safely for ... has become something of a celebrity material in recent ...
(Date:3/17/2010)... ... innovation to meet growing global needs sustainably. , ... Washington, DC (PRWEB) March 17, 2010 -- Studies released ... modern agriculture has provided to society and emphasized the importance of continued innovation and ...
(Date:3/17/2010)... March 17 /PRNewswire-FirstCall/ - Æterna Zentaris Inc. ( AEZS, TSX: AEZ) (the ... its fourth quarter and full year 2009 financial and operating results before market ... conference call and webcast to discuss these results later that same day at ... ...
Breaking Biology Technology:RIKEN Plant Science Center Research Reveals the Proteins That Help Plants Keep Time 2Layered graphene sheets could solve hydrogen storage issues 2Global Food Security Depends on Modern Agriculture 2Global Food Security Depends on Modern Agriculture 3Global Food Security Depends on Modern Agriculture 4Æterna Zentaris to Announce Fourth Quarter Full Year 2009 Financial and Operating Results on March 24, 2010 2
... from Preclinical and Clinical Studies Demonstrate Activity of ... Investigational Agent against Gram-Positive Bacteria, CHICAGO, ... Inc. (Nasdaq: THRX ) announced today results ... of,surgical-site-associated complicated skin and skin structure infections,(cSSSIs) from ...
... Texas, Sept. 18 Luminex Corporation,(Nasdaq: LMNX ... the fourth,annual America,s Growth Capital Emerging Growth Conference ... The investor presentation by Patrick J. Balthrop, president ... financial officer, will,begin at 8:30 a.m. Eastern time ...
... Increases Research Effort to Target Drug-Resistant Gram Negative ... ... GlaxoSmithKline (NYSE:,GSK) today announced that it has signed an agreement with ... (DOD), to,identify and develop a new class of antibacterials targeting both ...
Other Biology Technology:Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 2Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 3Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 4Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 5Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 6Luminex Corporation to Present at America's Growth Capital Emerging Growth Conference 2GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 2GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 3
(Date:3/18/2010)... , This release is available in Spanish ... female pigs as part of their regular diet makes them ... by Agricultural Research Service (ARS) scientists and cooperators. , The ... female pigs during the 8-month study. Tryptophan, which is only ...
(Date:3/18/2010)... an ongoing effort to mirror the ability of biological ... scientists from the McGowan Institute for Regenerative Medicine have ... both biological and chemical toxins. They described the findings ... biological principles to create materials that can do many ...
(Date:3/18/2010)... Wireless Information Network Studies (CWINS) at Worcester Polytechnic Institute ... the National Institute of Standards and Technology (NIST) to ... waves around and through the human body. Led by ... director of CWINS, the research will help speed the ...
Breaking Biology News(10 mins):Tryptophan-enriched diet reduces pig aggression 2Multifunctional polymer neutralizes both biological and chemical weapons 2WPI receives $1.2 million NIST award for pioneering study of wireless body area networks 2WPI receives $1.2 million NIST award for pioneering study of wireless body area networks 3New Day Pharmacy Receives 2410 2 Million in Growth Capital 51042 1New Day Pharmacy Receives 2410 2 Million in Growth Capital 51042 2Breakfast Anyone 3F Lifestyle Foods Launches Two Energizing Snacks Containing Under 200 Calories 51041 1Breakfast Anyone 3F Lifestyle Foods Launches Two Energizing Snacks Containing Under 200 Calories 51041 2Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway 51039 1Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway 51039 2
... that overexposure to ultraviolet rays from the sun can cause ... premature wrinkles. A tan, for example, is natures own UV ... , But what is not so well known ... and the complex organelles and proteins found inside every cell ...
... longer despite cellular defects, a discovery that is shedding ... doctors could one day limit or reverse genetic mutations ... of Colorado at Boulder study. , In the first ... state of genetically engineered lab worms called C. elegans ...
... Picture a pretzel factory production line, with conveyer belts carrying ... be cooked. , Now imagine what would happen if pretzel ... onto the conveyor, misshapen, and sticking fast to the dough of ... if that mess could no longer be conveyed into the oven, ...
Other Biology News:UVA researchers explain cell response to skin-damaging UV rays 2CU-Boulder worm study sheds light on human aging, inherited diseases 2CU-Boulder worm study sheds light on human aging, inherited diseases 3Botched production of insulin molecule may lead to diabetes 2Botched production of insulin molecule may lead to diabetes 3Botched production of insulin molecule may lead to diabetes 4
... The MagneGST™ Protein Purification System ... method for the purification of glutathione-S-transferase ... particles (MagneGST™ Particles) are used to ... crude or cleared lysate using either ...
... mechanical harvesting of cells • Blade design ... with the growth surface • Designed for ... Individually wrapped • Sterilized by gamma radiation ... is a new product number, created to ...
... Assay Kits are ideal for studying ... compounds using fluorescence polarization (FP) The ... glutathione transferase to the ligand binding ... and a proprietary, fluorescently-tagged progesterone ligand, ...
... base medium for preparation of minimal and synthetic ... does not contain amino acids. Both bulk and ... contains reagents to prepare 500 ml of 10X ... 10X YNB for S. cerevisiae media. Store at ...
Biology Products: